Trial Outcomes & Findings for Hormones and Social Anxiety Disorder Treatment (NCT NCT02482805)
NCT ID: NCT02482805
Last Updated: 2017-11-24
Results Overview
Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment. The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.
COMPLETED
NA
73 participants
Scores at 1 week post-treatment
2017-11-24
Participant Flow
Participant milestones
| Measure |
Power Posing
Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Submissive Posing
Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Rest
Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
|---|---|---|---|
|
Overall Study
STARTED
|
26
|
27
|
20
|
|
Overall Study
COMPLETED
|
22
|
23
|
20
|
|
Overall Study
NOT COMPLETED
|
4
|
4
|
0
|
Reasons for withdrawal
| Measure |
Power Posing
Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Submissive Posing
Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Rest
Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
|---|---|---|---|
|
Overall Study
Lost to Follow-up
|
4
|
4
|
0
|
Baseline Characteristics
Hormones and Social Anxiety Disorder Treatment
Baseline characteristics by cohort
| Measure |
Power Posing
n=26 Participants
Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Submissive Posing
n=27 Participants
Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Rest
n=20 Participants
Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Total
n=73 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
26.88 years
STANDARD_DEVIATION 6.99 • n=5 Participants
|
25.26 years
STANDARD_DEVIATION 8.99 • n=7 Participants
|
24.60 years
STANDARD_DEVIATION 5.83 • n=5 Participants
|
25.66 years
STANDARD_DEVIATION 7.48 • n=4 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
52 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
21 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
17 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
20 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
53 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
14 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
7 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
14 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
39 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
4 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
13 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
26 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
73 Participants
n=4 Participants
|
|
LSAS-performance
|
37.96 units on a scale
STANDARD_DEVIATION 14.39 • n=5 Participants
|
36.19 units on a scale
STANDARD_DEVIATION 10.92 • n=7 Participants
|
37.85 units on a scale
STANDARD_DEVIATION 10.16 • n=5 Participants
|
37.27 units on a scale
STANDARD_DEVIATION 11.96 • n=4 Participants
|
|
Peak SUDS during exposure
|
76.31 units on a scale
STANDARD_DEVIATION 14.86 • n=5 Participants
|
77.74 units on a scale
STANDARD_DEVIATION 15.03 • n=7 Participants
|
77.50 units on a scale
STANDARD_DEVIATION 11.20 • n=5 Participants
|
77.16 units on a scale
STANDARD_DEVIATION 13.85 • n=4 Participants
|
PRIMARY outcome
Timeframe: Scores at 1 week post-treatmentPopulation: 4 individuals did not complete LSAS at post-treatment; accordingly the analyses were conducted with only 69 individuals (versus the total sample size of 73) who had complete data.
Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment. The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.
Outcome measures
| Measure |
Power Posing
n=23 Participants
Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Submissive Posing
n=26 Participants
Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Rest
n=20 Participants
Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
|---|---|---|---|
|
LSAS-performance Subscale
|
34.04 units on a scale
Standard Deviation 14.76
|
32.54 units on a scale
Standard Deviation 8.74
|
32.05 units on a scale
Standard Deviation 13.70
|
PRIMARY outcome
Timeframe: Scores at 1 week post-treatmentPopulation: 8 individuals did not complete the post-treatment exposure; accordingly the analyses were conducted with only 66 individuals (versus the total sample size of 73) who had complete data.
Peak (max) SUDS ratings (0 to 100 scale) during treatment exposure and 1 week post-treatment exposure. Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.
Outcome measures
| Measure |
Power Posing
n=23 Participants
Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Submissive Posing
n=23 Participants
Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Rest
n=20 Participants
Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
|---|---|---|---|
|
Subjective Units of Distress Scale (SUDs)
|
59.26 units on a scale
Standard Deviation 14.43
|
59.17 units on a scale
Standard Deviation 23.85
|
48.75 units on a scale
Standard Deviation 19.79
|
PRIMARY outcome
Timeframe: Baseline and 20 minutes after posture manipulationSaliva sample taken before posture manipulation and 20 minutes after. Outcome is the change from pre- to post-manipulation in testosterone levels.
Outcome measures
| Measure |
Power Posing
n=26 Participants
Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Submissive Posing
n=27 Participants
Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
Rest
n=20 Participants
Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder
|
|---|---|---|---|
|
Salivary Testosterone Levels
|
-2.31 pg/mL
Standard Deviation 10.82
|
-0.88 pg/mL
Standard Deviation 33.31
|
-1.47 pg/mL
Standard Deviation 54.56
|
Adverse Events
Power Posing
Submissive Posing
Rest
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place